Andrew Ferguson

Andrew Ferguson has a diverse work experience in the field of clinical science. Andrew started their career in 2005 as a Postdoctoral Fellow at the University of Virginia and continued this role at the University of Virginia Health System until 2010. From 2010 to 2013, they worked as a Medical Science Liaison at Genzyme Corporation. Andrew then joined Sanofi as a Clinical Scientist in Clinical Development from 2013 to 2015. Andrew then joined TESARO, Inc. as a Clinical Scientist in 2015. Since 2016, Andrew has been working at Gritstone Oncology, where they held multiple roles including Director of Clinical Science and Vice President of Clinical Development. Currently, they serve as Vice President of Clinical Science at Gritstone Oncology.

Andrew Ferguson earned a Bachelor of Science degree in Biology from Wake Forest University from 1996 to 2000. Andrew then pursued a PhD in Immunology at Boston University School of Medicine from 2000 to 2005.